smartform 3.0 january, 2012

Post on 15-Feb-2016

37 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

DESCRIPTION

SMARTFORM 3.0 January, 2012. Overview of Major Changes. Why Make Changes?. Feedback from customers Annual Research Community Survey IRB Post Approval Survey - PowerPoint PPT Presentation

TRANSCRIPT

SMARTFORM 3.0January, 2012

Overview of Major Changes

Why Make Changes?• Feedback from customers

– Annual Research Community Survey– IRB Post Approval Survey

• Many of the webridge questions are tedious and can be found in the protocol easily. Further, some standard questions (i.e. rationale of exclusion of HIV patients) are standard within cancer protocols and providing generic answers to satisfy the application process seems like a waste of effort.

• Feedback from IRB Analyst Pre-Review– Comprehensive evaluation of additional information most commonly

requested during pre-review– Comprehensive review of questions posed during post –meeting

correspondence• Updates to address policy updates

Goals of the Enhancement• Combine “Description of Research”, Item #3, Sample Size Information, and “Clinical

Research Summary Form”• Allow for abbreviated application for certain research types (HUD, Compassionate Use, Case

Reports, etc)• Combine “Inclusion/Exclusion” and “Subject Population Checklist”, and Item #8 Process of

Informed Consent page• Address redundancy between “Analysis of Specimens/Data” and Prospective Collection

page• Address overlap in questions related to the use of investigational drugs and investigational

devices• Address redundancy among SCRO subpages• Revise prompts for relying on approvals issued by a non-CSMC IRB • Revise NCI IRB page to be inclusive of all reliance agreements• Eliminate redundant questions• Improve guidance and help text• Update previous GCRC pages to reflect recent CTSA grant

Any new staff team member added or deleted is now notified via email notification

Combined similar questions previously posed on three different pages, Description of Research, Clinical Research Summary and Sample Size Information

Converting Existing Studies

• Submissions in Process to Be Converted by IRB Analysts

• Approved Studies to be Converted by Study Staff at first Amendment

Edits to Continuation SMARTFORM

• Generalize for all facilitated review submissions

• Require additional information regarding DSMB reports

• Allow separate uploads for different reports• Allow uploads for closure notices• Add questions related to prior re-consent

Edits to Amendment SMARTFORM

• Combining discussion of proposed modifications and need for reconsent

• Clarification of wording

top related